Your browser doesn't support javascript.
loading
Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype.
Kosiborod, Mikhail N; Abildstrøm, Steen Z; Borlaug, Barry A; Butler, Javed; Christensen, Louise; Davies, Melanie; Hovingh, Kees G; Kitzman, Dalane W; Lindegaard, Marie L; Møller, Daniél Vega; Shah, Sanjiv J; Treppendahl, Marianne Bach; Verma, Subodh; Petrie, Mark C.
Afiliación
  • Kosiborod MN; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA. Electronic address: mkosiborod@saint-lukes.org.
  • Abildstrøm SZ; Novo Nordisk A/S, Søborg, Denmark.
  • Borlaug BA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Butler J; Baylor Scott and White Research Institute, Dallas, Texas, USA; Department of Medicine, University of Mississippi, Jackson, Mississippi, USA. Electronic address: https://twitter.com/JavedButler1.
  • Christensen L; Novo Nordisk A/S, Søborg, Denmark.
  • Davies M; Diabetes Research Centre, University of Leicester, Leicester, United Kingdom; National Institute for Health Care and Research, Leicester Biomedical Research Centre, Leicester, United Kingdom.
  • Hovingh KG; Novo Nordisk A/S, Søborg, Denmark.
  • Kitzman DW; Department of Internal Medicine, Sections of Cardiovascular Medicine and Geriatrics and Gerontology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Lindegaard ML; Novo Nordisk A/S, Søborg, Denmark.
  • Møller DV; Novo Nordisk A/S, Søborg, Denmark.
  • Shah SJ; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Electronic address: https://twitter.com/HFpEF.
  • Treppendahl MB; Novo Nordisk A/S, Søborg, Denmark.
  • Verma S; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada.
  • Petrie MC; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom. Electronic address: https://twitter.com/markcpetrie20.
JACC Heart Fail ; 11(8 Pt 1): 1000-1010, 2023 08.
Article en En | MEDLINE | ID: mdl-37294245
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Female / Humans / Male Idioma: En Revista: JACC Heart Fail Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Female / Humans / Male Idioma: En Revista: JACC Heart Fail Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos